[1]李泽芹.降钙素联合阿仑膦酸盐治疗原发性骨质疏松症有效性评价[J].医学信息,2021,34(17):154-156.[doi:10.3969/j.issn.1006-1959.2021.17.041]
　LI Ze-qin.Evaluation of the Effectiveness of Calcitonin Combined with Alendronate Sodium in the Treatment of Primary Osteoporosis[J].Medical Information,2021,34(17):154-156.[doi:10.3969/j.issn.1006-1959.2021.17.041]
点击复制

降钙素联合阿仑膦酸盐治疗原发性骨质疏松症有效性评价()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年17期
页码:
154-156
栏目:
药物与临床
出版日期:
2021-09-01

文章信息/Info

Title:
Evaluation of the Effectiveness of Calcitonin Combined with Alendronate Sodium in the Treatment of Primary Osteoporosis
文章编号:
1006-1959（2021）17-0154-03
作者:
李泽芹
（天津市第一医院骨科，天津 300232）
Author(s):
LI Ze-qin
(Department of Orthopedics,Tianjin First Hospital,Tianjin 300232,China)
关键词:
降钙素; 阿仑膦酸盐; 骨质疏松症; 骨密度; Oswestry 功能障碍指数
Keywords:
Calcitonin; Alendronate sodium; Osteoporosis; Bone mineral density; Oswestry dysfunction index
分类号:
R683
DOI:
10.3969/j.issn.1006-1959.2021.17.041
文献标志码:
A
摘要:
目的 观察降钙素联合阿仑膦酸盐治疗原发性骨质疏松症有效性。方法 选取2017年5月-2020年5月在我院诊治的66例原发性骨质疏松症患者为研究对象，采用随机数字表法分为对照组和观察组，各33例。对照组采用阿仑膦酸盐治疗，观察组在对照组基础上联合降钙素治疗。比较两组治疗总有效率、临床症状评分、骨密度、Oswestry 功能障碍指数、不良反应发生情况。结果 观察组治疗总有效率为93.93%，高于对照组的81.81%，差异有统计学意义（P＜0.05）；治疗后，观察组步履艰难、下肢痿弱、腰膝酸软、腰脊刺痛评分均低于对照组，差异有统计学意义（P＜0.05）；治疗后两组腰椎正位（L2~4）、右股骨颈骨密度均高于治疗前，且观察组高于对照组，差异有统计学意义（P＜0.05）；治疗后两组Oswestry 功能障碍指数均低于治疗前，且观察组低于对照组，差异有统计学意义（P＜0.05）；观察组不良反应发生率为6.06%，与对照组的9.09%比较，差异无统计学意义（P＞0.05）。结论 降钙素联合阿仑膦酸盐治疗原发性骨质疏松症确切有效，可提高临床治疗总有效率，改善临床症状，提高骨密度，降低功能障碍评分，促进功能恢复，且不良反应少，临床应用安全性良好。
Abstract:
Objective To observe the effectiveness of calcitonin combined with alendronate sodium in the treatment of primary osteoporosis.Methods 66 patients with primary osteoporosis who were diagnosed and treated in our hospital from May 2017 to May 2020 were selected as the research objects. They were divided into control group and observation group by random number table method, with 33 cases in each group.The control group was treated with alendronate sodium, and the observation group was treated with calcitonin on the basis of the control group.The total effective rate of clinical treatment, clinical symptom score, bone mineral density, Oswestry dysfunction index, and occurrence of adverse reactions were compared between the two groups.Results The total effective rate of treatment in the observation group was 93.93%, which was higher than 81.81% in the control group,the difference was statistically significant (P＜0.05);After treatment, the observation group’s difficult walking, weak lower limbs, waist and knee soreness, and lumbar spine tingling scores were all lower than those of the control group, the difference was statistically significant (P＜0.05);After treatment, the bone mineral density of the lumbar spine (L2-4) and the right femoral neck of the two groups were higher than before treatment, and the observation group was higher than the control group, the difference was statistically significant (P＜0.05);After treatment, the Oswestry dysfunction index of the two groups was lower than before treatment, and the observation group was lower than the control group, the difference was statistically significant (P＜0.05);The incidence of adverse reactions in the observation group was 6.06% compared with 9.09% in the control group,the difference was not statistically significant (P＞0.05).Conclusion Calcitonin combined with alendronate sodium is definitely effective in treating primary osteoporosis.It can increase the total effective rate of clinical treatment, improve clinical symptoms, increase bone density, reduce dysfunction scores, promote functional recovery, and have fewer adverse reactions and good clinical application safety.

参考文献/References:

[1]中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-444. [2]葛继荣,郑洪新,万小明,等.中医药防治原发性骨质疏松症专家共识(2015)[J].中国骨质疏松杂志,2015,21(9):1023-1028. [3]丁诤,曾光.尿毒症维持性透析致骨质疏松患者补钙治疗效果的影响因素[J].医学临床研究,2017,34(2): 253-255. [4]Otero M,Esain I,Gonzalez-Suarez AM,et al.The effectiveness of a basic exercise intervention to improve strength and balance in women with osteoporosis[J].Clin Interv Aging,2017(12):505-513. [5]权朋勃,王明礼,郭得辛,等.注射型唑来膦酸与阿仑膦酸钠治疗绝经后骨质疏松症的临床比较[J].中国妇幼保健,2014,29(8):1283-1285. [6]黄杰文,刘海全.强骨胶囊对老年性骨质疏松症骨形成的影响[J].临床医学工程,2016,23(7):871-872. [7]Logan S,Thu WPP,Lay WK,et al.Chronic joint pain and handgrip strength correlates with osteoporosis in mid-life women:a Singaporean cohort[J].Osteoporos Int,2017,28(9):2633-2643. [8]李萍,肖碧,唐芸,等.老年骨质疏松患者接受双膦酸盐治疗急性期不良反应分析[J].中国医师杂志,2016,18(3):362-365,369. [9]刘宇航,张永明,王建华.唑来磷酸钠联合骨化三醇治疗原发性骨质疏松症的疗效观察[J].中华老年骨科与康复电子杂志,2019,5(4):206-210. [10]吴雪妍.综合治疗原发性骨质疏松症临床效果观察[J].临床合理用药杂志,2015(11):119-120. [11]邹艺,李笑,王倩,等.鲑鱼降钙素注射液与唑来膦酸钠注射液治疗绝经后骨质疏松症的临床疗效对比[J].中国骨质疏松杂志,2018,24(8):69-73. [12]王芬.唑来膦酸钠注射液和鲑鱼降钙素注射液治疗绝经后骨质疏松症的效果比较[J].北方药学,2019,16(9):118-119. [13]翁科迪,蒋国华,石钢,等.阿仑膦酸钠联合鲑鱼降钙素对老年髋部骨质疏松性骨折患者的疗效及对骨密度和骨代谢标志物的影响[J].中国老年学杂志,2020,40(21):4597-4599. [14]亢鸿儒.唑来膦酸注射液+钙制剂+VD对骨质疏松患者症状缓解情况的对照研究[J].中国实用医刊,2016,43(7):29-30. [15]王驰.密钙息在骨质疏松性脊柱压缩骨折治疗中的应用研究[J].吉林医学,2014,35(1):91.

相似文献/References:

[1]黄应钟,杨立进.序贯抗骨质疏松对老年股骨粗隆间骨折愈合时间及再骨折的影响[J].医学信息,2021,34(18):94.[doi:10.3969/j.issn.1006-1959.2021.18.024]
　HUANG Ying-zhong,YANG Li-jin.The Effect of Sequential Anti-osteoporosis on the Healing Time ofIntertrochanteric Fracture and Re-fracture in the Elderly[J].Medical Information,2021,34(17):94.[doi:10.3969/j.issn.1006-1959.2021.18.024]

更新日期/Last Update: 1900-01-01